MedPath
TGA Approval

HALAVEN eribulin mesilate 1 mg/2 mL solution for injection glass vial (187136)

187136

HALAVEN eribulin mesilate 1 mg/2 mL solution for injection glass vial

Eisai Australia Pty Ltd

September 4, 2012

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/d4478ad23321708204fb699d0597b769.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/1088876fa07b255878441e172cecc651.pdf

Active Ingredients

eribulin mesilate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

HALAVEN eribulin mesilate 1 mg/2 mL solution for injection glass vial (187136) - TGA 批准文号 | MedPath